COMPOSITION / SINGLE
L-CARNITINE
600MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A naturally occurring amino-acid derivative studied in fatty-acid transport and metabolic research.
Available Strengths
- 600MG (LC600)
Research Protocol
Reference gradual titration
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 50 mg | 50 | 0.5 mL |
| Weeks 3–12+ | 100 mg | 100 | 1 mL |
| Advanced (optional) | 200 mg | 200 | 2 mL |
Reconstitution
≈100 mg/mL once reconstituted
- Draw 6.0 mL of bacteriostatic water per 600 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Transports long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation and ATP production; subcutaneous delivery is reported to offer far higher bioavailability than oral dosing and to bypass gut-bacterial conversion to TMAO.
Storage
−20°C or below; stable months to years. 2–8°C, use within 2–4 weeks; avoid freeze–thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
- DXBTides' 600 mg vial has no dedicated source page; the source's own 200 mg vial page was used, holding its 100 mg/mL concentration constant and scaling reconstitution water up to 6.0 mL for this larger vial — the daily mg dose and resulting injection volumes are unchanged from the source's own figures.
References
Source reference: PeptideDosages.com · 2026-08-18 · Mathematically derived for this strength from the compound's verified reference data